Abstract:Objective:Glioma is one of the most frequently seen malignant tumors in the central nervous system.Alkylating agents such as l,3-bis(2-chloroethyl)-1-nitrosourea(BCNU) are among the most effective cytotoxic agents for these patients,but the responses remain very poor.The adenosine triphosphate binding cassette(ABC) transporter family,whose products represent membrane proteins,have the capability to use energy to drive the transporters of various molecules across the cellular membrane,and are confirmed to be associated with anticancer drug transporters.At present,11 ABC transporters have been found to be involved in drug resistance. In the present study,the glioma cell lines SWOZl and SWOZ2,which were isolated and cloned from the same parental cell line SW038,were used to investigate the relationship between the expression of 11 ABC transporters and BCNU resistance in gliomas. Methods:The glioma cell line SWOZ2,which is sensitive to BCNU treatment,was taken as the control,and glioma cell line SWOZl, which is resistant to BCNU,was taken as the intrinsic resistant cell line.BCNU-resistant cells SWOZ2/B,derived from SWOZ2,were taken as the acquired resistant cell line.A CCK-8 assay was used to determine the growth curve of the cells,and also the IC50 values and resistance indices(RI) to BCNU of each cell line.Quantitative RT-PCR was used to evaluate the modulation of the expression of the eleven ABC transporters related to drug resistance in these cell lines.Results:No significance was found between the growth curves of the cell lines.Based on the results of the CCK-8 assay,the IC50 value of the cell lines SWOZl and SWOZ2/B against BCNU was(16.17±1.62) and(22.38±1.08) ng/mL,respectively.The resistance of SWOZl and SWOZ2/B were 4.7-fold and 6.5-fold more than that of the cell line SWOZ2[(3.47±0.86)μg/mL],respectively.The results of quantitative RT-PCR revealed that only ABCGl was overexpressed both in the intrinsic and acquired BCNU-resistant cell lines SWOZ1 and SWOZ2/B,compared with the BCNU -sensitive cell line SWOZ2.The upregulation of ABCG1 expression was 4.1-fold and 4.4-fold in the SWOZl and SWOZ2/B cell lines than in the cell line SWOZ2.Conclusion:Our data indicate that ABCGl may play an important role in the resistance of glioma cells to BCNU.

Elevated Expression of Solute Carrier Family 22 Member 18 Increases the Sensitivity of U251 Glioma Cells to BCNU

In Vitro and in Vivo Radiosensitization of Human Glioma U251 Cells Induced by Upregulated Expression of SLC22A18

Effects of SLC22A18 Gene on Chemosensitivity of U251 Human Glioma Cells

Influence of SLC22A18 Gene Expression on the Biological Behaviors of Glioma Cells

Expression of Dedifferentiation Markers and Multilineage Markers in U251 Glioblastoma Cells with Silenced EGFR and FGFR Genes.

Evaluation of Combination Gene Therapy with SLC22A18 Upregulation and Sequence Binding Protein 1 Downregulation for Glioma U251 Cells in Vitro and in Vivo

Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in Glioma U251 Cells.

The Candidate Tumor Suppressor Gene SLC8A2 Inhibits Invasion, Angiogenesis and Growth of Glioblastoma.

Effect of solute carrier family 8, member 2 on invasion, migration and in vivo xenograft growth of glioma cell line U87

Promoter Methylation and Downregulation of SLC22A18 Are Associated with the Development and Progression of Human Glioma

SLC25A21 Suppresses Cell Growth in Bladder Cancer Via The Reactive Oxygen Species-Mediated Mitochondrion-Dependent Apoptosis Pathway

Relationship Between Aberrant Methylation of SLC22A18 Gene Promoter and SLC22A18 Expression in Glioma

Overcoming acquired resistance by SLC22A18 silencing in human glioma

Elevated SLC3A2 associated with poor prognosis and enhanced malignancy in gliomas

Elevated Expression of Dickkopf-1 Increases the Sensitivity of Human Glioma Cell Line SHG44 to BCNU.

Expression of Eleven ABC Transporters in BCNU-resistant Glioma Cell Lines

Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.

Bulk and Single Cells Transcriptomes with Experimental Validation Identify USP18 As a Novel Glioma Prognosis and Proliferation Indicator

Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer

Correlation of Low SLC22A18 Expression with Poor Prognosis in Patients with Glioma.